Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tubulin-targeting agents

William N Hait1, Eric Rubin, Susan Goodin

  • 1UMDNJ/Robert Wood Johnson Medical School, Departments of Medicine and Pharmacology, Cancer Institute of New Jersey, 195 Little Albany Street, New Brunswick, NJ, USA. haitwn@u.ndnj.edu

Cancer Chemotherapy and Biological Response Modifiers
|April 22, 2003
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Activation mechanism and structural assembly of the Mycobacterium tuberculosis ClpP1P2 protease and its associated ATPases.

Cell reports·2026
Same author

Public Health Alerts - A New Section in <i>NEJM Evidence</i>, in Partnership with CIDRAP.

NEJM evidence·2025
Same author

Afterhours diagnostic radiology in the USA: radiologists' views on imaging volumes, compensation, work-from-home, and compensatory time-off.

Emergency radiology·2025
Same author

Thinking about a move from academia to industry? Look before you leap.

Nature biotechnology·2025
Same author

The State of Paid Family and Medical Leave Policies: An ACR, AAWR, SWRO Member Survey.

Journal of the American College of Radiology : JACR·2025
Same author

Academic entrepreneurship: promise and perils.

Trends in biotechnology·2025
Same journal

Native and genetically engineered anti-disialoganglioside monoclonal antibody treatment of melanoma.

Cancer chemotherapy and biological response modifiers·2005
Same journal

Human tumor associated antigen mimicry by xenoantigens, anti-idiotypic antibodies and peptide mimics: implications for immunotherapy of malignant diseases.

Cancer chemotherapy and biological response modifiers·2005
Same journal

DNA vaccines for melanoma.

Cancer chemotherapy and biological response modifiers·2005
Same journal

Immunizing against partially defined antigen mixtures, gangliosides, or peptides to induce antibody, T cell, and clinical responses.

Cancer chemotherapy and biological response modifiers·2005
Same journal

Chemotherapy, cytokines, and biochemotherapy for melanoma.

Cancer chemotherapy and biological response modifiers·2005
Same journal

Current status of interferon-alpha in the treatment of melanoma.

Cancer chemotherapy and biological response modifiers·2005
See all related articles